Biotech Stock Watch List - Opexa Therapeutics Inc. (NASDAQ:OPXA), Gilead Sciences, Inc. (NASDAQ:GILD), Protalix BioTherapeutics Inc. (NYSE:PLX), Celsion Corp (NASDAQ:CLSN)

Scottsdale, AZ -- (SBWIRE) -- 02/05/2013 -- Opexa Therapeutics Inc. (NASDAQ:OPXA) shares boosted after it declared that it has entered into an agreement with Merck Serono, for the growth and commercialization of Tcelna, a potential first-in-class personalized T-cell therapy for patients with multiple sclerosis.

During the mid-day trading hours, Opexa Therapeutics Inc. (NASDAQ:OPXA) skyrocketed to +207.44% and $3.71 with the total traded volume of 4.95 million shares. OPXA has outstanding shares of 5.76 million with the total market cap of 21.73 million and its beta value stands at 1.70 times.

What was the Moving Force behind OPXA On Bullish Run? Read This Research Report

Gilead Sciences, Inc. (NASDAQ:GILD) shares went up after it declared topline results from two Phase 3 studies, FISSION and NEUTRINO, assessing a 12-week course of the once-daily nucleotide sofosbuvir in grouping with ribavirin (FISSION) and in combination with ribavirin and pegylated interferon (NEUTRINO) amid treatment-naïve patients with chronic hepatitis C virus (HCV) infection.

In the mid-day, Gilead Sciences, Inc. (NASDAQ:GILD) surged +2.56% to $40.62 with the total traded volume of 4.97 million shares. Stock price 52 weeks high was $41.34 and 52 weeks low price was $21.91.

Will GILD Continue To Move Higher? Find Out Here

Protalix BioTherapeutics Inc. (NYSE:PLX) reported the gain of +16.59% to $6.25 in the mid-day with the total traded volume of 4.36 million shares. Its fifty two week range was $4.71-$7.70. The total market capitalization remained $501.00 million.

PLX is ahead its 52 week low with 32.91% and its last month price volatility remained 3.46%. Its beta coefficient was 1.17 with a target price of $6.00. In its share capital PLX has 93.47 million outstanding shares while 69.37 million shares have been floated in market. PLX has insider ownership of 19.59% with its institutional ownership remained 19.61%.

For How Long PLX’s Gloss will Attract Investors? Find out via this report

Celsion Corporation (NASDAQ:CLSN) moved up +3.42% to $1.21 in the mid-day trading hours with the total traded volume of 4.15 million shares. CLSN has stock price 52 weeks high was $9.44 and 52 weeks low price was $1.13. CLSN has market cap of 42.21 million.

Why Should Investors Buy CLSN After The Recent Gain? Just Go Here and Find Out

About Universal Penny Stocks
universalpennystocks.com is an Independent Company, our focus is on small cap stocks that trade on OTCBB and OTC markets, and are mostly referred to as “penny stocks”. These are stocks that normally trade under $5 a share and could offer the greatest potential return on your short or long term investment. You must read our Disclaimer page for more information regarding conflicts of interest and the risks involved.

We try to spot stocks in all types of market conditions. In addition, we provide emerging small cap companies with profiling and investor relations services for compensation. If you believe your company is an emerging company, with a solid product, or a company that offers our members a profitable short or long term opportunity please feel free to send us an e-mail and we’ll review the company and reply to your inquiry promptly. Please provide as much information you believe we’ll need to review your request.